Comparison of incidence/occurrence of cardiovascular events between ponatinib vs bosutinib among patients with at least one prior line of tyrosine kinase inhibitors in chronic myeloid leukemia in a community setting in the United States
- Resource Type
- Article
- Source
- In
Cancer Treatment and Research Communications 2021 28 - Subject
- Language
- ISSN
- 2468-2942